Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study (Q44799764)
Jump to navigation
Jump to search
scientific article published in January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study |
scientific article published in January 2004 |
Statements
1 reference
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study (English)
1 reference
Hiromi Kumon
1 reference
Hideyuki Akaza
1 reference
Akito Yamaguchi
1 reference
Tadashi Matsuda
1 reference
Mikio Igawa
1 reference
Asaki Soeda
1 reference
Yoichi Arai
1 reference
Michiyuki Usami
1 reference
Seiji Naito
1 reference
Hiroshi Kanetake
1 reference
Yasuo Ohashi
1 reference
1 January 2004
1 reference
1 reference
Identifiers
1 reference